Collaboration for containment: Detection of OXA-23-like carbapenamase-producing Acinetobacter baumannii in Colorado

Infect Control Hosp Epidemiol. 2018 Oct;39(10):1273-1274. doi: 10.1017/ice.2018.202. Epub 2018 Aug 30.

Authors

Heather L Young¹, Caroline Croyle², Sarah J Janelle³, Bryan C Knepper², Jennifer Kurtz², Amber Miller⁴, Sara M Reese⁵, Kyle Schutz³, Wendy M Bamberg³

Affiliations

¹ 1Department of Medicine,Denver Health Medical Center and University of Colorado School of Medicine,Denver,Colorado.
² 2Department of Patient Safety and Quality,Denver Health Medical Center,Denver,Colorado.
³ 3Colorado Department of Public Health and Environment,Denver,Colorado.
⁴ 4Department of Planning and Construction,University of Colorado Health,Aurora, Colorado.
⁵ 5Department of Quality.Swedish Medical Center,Denver,Colorado.

PMID: 30160227
DOI: 10.1017/ice.2018.202

No abstract available

Publication types

Letter

MeSH terms

Acinetobacter Infections / microbiology
Acinetobacter baumannii / drug effects*
Acinetobacter baumannii / enzymology*
Acinetobacter baumannii / isolation & purification
Anti-Bacterial Agents / pharmacology*
Bacterial Proteins / genetics*
Bacterial Proteins / metabolism
Carbapenems / pharmacology
Colorado
Humans
Microbial Sensitivity Tests
beta-Lactam Resistance
beta-Lactamases / genetics*
beta-Lactamases / metabolism

Substances

Anti-Bacterial Agents
Bacterial Proteins
Carbapenems
beta-Lactamases
carbapenemase